SEC Form 4 Reporting Owner · CIK 0001914448

Eliana Clark

CTO at Intellia Therapeutics Inc

Bought (12 mo) —
Sold (12 mo) −$96K
Form 4 Filings 13
Companies 1
Filing Activity 2026-03-03 first filed 2022-03-07

Trading record

Open-market buys — 0 filings
Open-market sales −$690K 11 filings
Sales under a 10b5-1 plan 9% 1 of 11 sale filings · 1 undisclosed

Companies

Open-market shares bought and sold at each company, and the holding after the latest filing
CompanyRoleFilingsBoughtSoldNetHolding after latest filing
NTLAIntellia Therapeutics Insider tradingCTO13—32,807−32,80794,471 2026-03-03

Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.

Insider Trading History

Company Type Value Filed View filing
NTLA Intellia Therapeutics Inc Sell -$8,364 2026-03-03
NTLA Intellia Therapeutics Inc Sell -$87,633 2026-01-07
NTLA Intellia Therapeutics Inc Sell -$10,036 2025-07-03
NTLA Intellia Therapeutics Inc Sell -$6,104 2025-03-04
NTLA Intellia Therapeutics Inc Sell -$97,089 2025-01-06
NTLA Intellia Therapeutics Inc Sell -$9,287 2024-07-03
NTLA Intellia Therapeutics Inc Sell -$19,959 2024-03-05
NTLA Intellia Therapeutics Inc Sell -$135,954 2024-01-05
NTLA Intellia Therapeutics Inc Sell -$14,584 2023-07-06
NTLA Intellia Therapeutics Inc Sell -$225,000 2023-06-22
NTLA Intellia Therapeutics Inc Award — 2023-03-03
NTLA Intellia Therapeutics Inc Sell -$76,357 2023-01-06
NTLA Intellia Therapeutics Inc Award — 2022-03-07